[The character of distribution of HLA specificities in oncological patients.]
The study results permitted to surmise that gene HLA-B*54 class I can be considered in population as a resistant one in relation to development of oncohematological diseases. HLA-B*38, HLA-DRB1*13can be considered as genes having protective effect in relation to development of oncohematological diseases. At a given point of time, there is no statistically reliable differences in loci HLA-A, HLA-C, HLA-DQB1 that testify necessity of further investigation of HLA system in relation to oncohematological diseases.